Literature DB >> 6254648

Effect of ovariectomy on hormone receptors and growth of N-nitrosomethylurea-induced mammary tumors in the rat.

B M Arafah, P M Gullino, A Manni, O H Pearson.   

Abstract

Estrogen receptor(s) (ER), progesterone receptor(s) (PGR), androgen receptor(s) (ANR), and prolactin receptor(s) (PRLR) were measured in N-nitrosomethylurea-induced mammary tumors in intact female Sprague-Dawley rats and in rats 9 days after ovariectomy. Following ovariectomy, 12 of 15 tumors regressed to 47.7 +/- 5.5% of the original size (hormone-dependent tumors), while the remaining three had arrest of growth reaching 88.8 +/- 7.3% of their original sizes. Cytosol ER level was 50.3 +/- 6.6 fmol/mg protein in tumors of intact rats and was significantly lower (25.6 +/- 8.3 fmol/mg, p < 0.025) in the ovariectomized group. PGR was abundantly present in ten of 13 tumors of intact rats (mean, 144.5 +/- 46.8) but was undetectable in five of six hormone-dependent tumors after ovariectomy (p < 0.01). ANR ws detectable at low levels in only four of 13 tumors of intact rats but in none of six hormone-dependent tumors after ovariectomy. PRLR was not significantly different in tumors of intact and ovariectomized rats (20.6 +/- 2.4 and 15.6 +/- 1.8 fmol/mg, respectively). In three tumors that had arrest of growth after ovariectomy, the levels of ER, PGR, ANR, and PRLR were not significantly different from those of the hormone-dependent tumors. We conclude that the majority of N-nitrosomethylurea-induced rat mammary tumors are hormone dependent. ER, PGR, and PRLR were abundantly present in the majority of these tumors, while ANR was present in only four of 13 tumors. The levels of ER and PGR were significantly lower following ovariectomy, while PRLR was not significantly changed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254648

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptor.

Authors:  M Görlich; G Winterfeld; P Hauff; W Arnold; I Fichtner; H J Staab
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia.

Authors:  David L Kleinberg; Pietro Ameri; Baljit Singh
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

3.  Human adenovirus type 9-induced rat mammary tumors.

Authors:  R Javier; K Raska; G J Macdonald; T Shenk
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  Androgen-linked alkylating agents: biological activity in methylnitrosourea-induced rat mammary carcinoma.

Authors:  H P Brix; M R Berger; M R Schneider; W C Tang; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

5.  Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.

Authors:  J E Moreno-Cuevas; D A Sirbasku
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Jul-Aug       Impact factor: 2.416

6.  Isolation and characterization of a serially cultivated, neoplastic, epithelial cell line from the N-nitrosomethylurea induced rat mammary adenocarcinoma.

Authors:  L A Cohen
Journal:  In Vitro       Date:  1982-06

7.  Investigations of droloxifene and other hormone manipulations on N-nitrosomethylurea-induced rat mammary tumours. 1. Influence on tumour growth.

Authors:  G Winterfeld; P Hauff; M Görlich; W Arnold; I Fichtner; H J Staab
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

8.  Effects of endocrine therapy on steroid-receptor content of breast cancer.

Authors:  R E Taylor; T J Powles; J Humphreys; R Bettelheim; M Dowsett; A J Casey; A M Neville; R C Coombes
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

9.  Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment.

Authors:  Makoto Asamoto; Tomonori Ota; Hiroyasu Toriyama-Baba; Naomi Hokaiwado; Akihiro Naito; Hiroyuki Tsuda
Journal:  Jpn J Cancer Res       Date:  2002-01

10.  Spontaneously metastasizing variants derived from MNU-induced rat mammary tumour.

Authors:  J C Williams; B A Gusterson; R C Coombes
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.